Top Markets
#1 Palladium Network Palladium Network +6.67%
#2 Victoria VR Victoria VR +4.08%
#3 Bridged NXPC Bridged NXPC +2.08%
#4 Tornado Cash Tornado Cash +2.06%
#5 龙虾 (Lobster) 龙虾 (Lobster) +1.72%
#6 aixbt by Virtuals aixbt by Virtuals +1.55%
#7 Prom Prom +1.52%
#8 SkyAI SkyAI +1.49%
#9 Wiki Cat Wiki Cat +1.14%
#10 Geodnet Geodnet +0.92%
Coin of the day
Palladium Network Palladium Network
Innstillinger
Språk
NORSK
Valuta
USD
Tema
GeneThera, Inc. GeneThera, Inc.

GeneThera, Inc.

GTHR
Rangering i aksjer #42192
GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced... GeneThera, Inc. is a biotechnology firm dedicated to crafting advanced diagnostic tools and therapeutic solutions for diseases that can transfer from animals to humans (zoonotic diseases). The company's portfolio includes treatments for a variety of these conditions, such as COVID-19, and illnesses like paratuberculosis (Johne's disease), currently in its Stage III clinical phase, as well as mad cow and chronic wasting diseases, and common bacterial infections like E.coli and salmonella. Furthermore, GeneThera is developing a vaccine specifically targeting Mycobacterium avium subspecies paratuberculosis bacteria. Utilizing its innovative Molecular Robotic/AI Platform and a strategic therapeutic framework, the company strives to inhibit the spread of animal-borne diseases and improve control over zoonotic infectious agents. GeneThera, Inc. operates out of Westminster, Colorado.
Aksjekurs
$0.0001
Sist synkronisert: 2025-03-10
Markedsverdi
$3.53K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel GeneThera, Inc. (GTHR)

Kategori

Healthcare
Inntekter for GeneThera, Inc. (GTHR)
Inntekter i Aug 2026 TTM: 0
Ifølge de nyeste økonomiske rapportene til GeneThera, Inc. er selskapets nåværende inntekter (TTM) 0. I 2026 hadde selskapet inntekter på 0 lik inntektene i 2026, som var 0. Inntektene er det totale beløpet et selskap genererer fra salg av varer eller tjenester. I motsetning til fortjeneste trekkes ingen kostnader fra.
Inntektshistorikk for GeneThera, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR